C112H97Cl5N44O11S5 — CID 159593284
N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-pyridin-3-ylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide (PubChem CID 159593284) has the molecular formula C112H97Cl5N44O11S5 and a molecular weight of 2572.90 g/mol. Its IUPAC name is N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-pyridin-3-ylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide.
| Compound Name | N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-pyridin-3-ylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide |
|---|---|
| PubChem CID | 159593284 |
| Molecular Formula | C112H97Cl5N44O11S5 |
| Molecular Weight | 2572.90 g/mol |
| Exact Mass | 2568.54 |
| IUPAC Name | N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-cyclopentylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-(1-methylpyrrol-3-yl)methanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-(oxan-4-yl)ethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-2-pyridin-3-ylethanesulfonamide;N-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-1-pyrimidin-5-ylmethanesulfonamide |
| SMILES | Cn1ccc(-c2nc(NS(=O)(=O)CCC3CCCC3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(-c2nc(NS(=O)(=O)CCC3CCOCC3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(-c2nc(NS(=O)(=O)CCc3cccnc3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(-c2nc(NS(=O)(=O)Cc3cncnc3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(CS(=O)(=O)Nc2nc(-c3ccn(C)n3)c(-c3cc(Cl)c4[nH]ncc4c3)nc2C#N)c1 |
| InChI | InChI=1S/C23H18ClN9O2S.C23H23ClN8O3S.C23H23ClN8O2S.C22H18ClN9O2S.C21H15ClN10O2S/c1-33-7-4-18(31-33)22-21(15-9-16-13-27-30-20(16)17(24)10-15)28-19(11-25)23(29-22)32-36(34,35)8-5-14-3-2-6-26-12-14;1-32-6-2-18(30-32)22-21(15-10-16-13-26-29-20(16)17(24)11-15)27-19(12-25)23(28-22)31-36(33,34)9-5-14-3-7-35-8-4-14;1-32-8-6-18(30-32)22-21(15-10-16-13-26-29-20(16)17(24)11-15)27-19(12-25)23(28-22)31-35(33,34)9-7-14-4-2-3-5-14;1-31-5-3-13(11-31)12-35(33,34)30-22-18(9-24)26-20(21(27-22)17-4-6-32(2)29-17)14-7-15-10-25-28-19(15)16(23)8-14;1-32-3-2-16(30-32)20-19(13-4-14-9-26-29-18(14)15(22)5-13)27-17(6-23)21(28-20)31-35(33,34)10-12-7-24-11-25-8-12/h2-4,6-7,9-10,12-13H,5,8H2,1H3,(H,27,30)(H,29,32);2,6,10-11,13-14H,3-5,7-9H2,1H3,(H,26,29)(H,28,31);6,8,10-11,13-14H,2-5,7,9H2,1H3,(H,26,29)(H,28,31);3-8,10-11H,12H2,1-2H3,(H,25,28)(H,27,30);2-5,7-9,11H,10H2,1H3,(H,26,29)(H,28,31) |
| InChIKey | MKMXZRPZWGIDPU-UHFFFAOYSA-N |
| XLogP | 17.00 |
| TPSA | 764.03 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 177 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2572.90 |
| LogP ≤ 5 | 17.00 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 45 |